Eucrates Biomedical Acquisition (EUCR) Stock Price, News & Analysis

Company Overview

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

Key Stats

• Today's Range: $10.02 to $10.04
• 50-Day Range: $10.04 to $10.25
• 52-Week Range: $9.87 to $10.25
• Volume: 12,700 shs
• Average Volume: 2,287 shs
• Market Capitalization: $42.27 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EUCR Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Eucrates Biomedical Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Eucrates Biomedical Acquisition investors own include Sprott Focus Trust (FUND), Meta Platforms (META), ETFMG Alternative Harvest ETF (MJX), New Zealand Energy (NZ), Strathcona Resources (SCR) and Shopify (SHOP).

Company Calendar

• Today: 7/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: Holding & other investment offices
• Sub-Industry: N/A
• Current Symbol: NASDAQ:EUCR
• CIK: 1822929
• Web: N/A
• Phone: 212-710-5220
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $2.42 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -62.82%
• Return on Assets: 2.95%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.03
• Quick Ratio: 2.03

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: $0.81 per share
• Price / Cash Flow: 12.36
• Book Value: ($1.25) per share
• Price / Book: -8.03

Miscellaneous

• Outstanding Shares: 4,210,000
• Free Float: 3,386,000
• Market Cap: $42.27 million
• Optionable: Not Optionable
• Beta: -0.07